Switching course, Gilead markets HIV drug for prevention

By Jilian Mincer NEW YORK (Reuters) – Gilead Sciences Inc has begun marketing its HIV treatment Truvada in a way thousands of consumers already use it – to prevent infection with the virus that causes AIDS. The company introduced Truvada to the U.S. market in 2004 for HIV treatment. In 2012, Gilead won approval to market it for prevention after two large, peer-reviewed studies showed it also was effective at preventing infections in healthy people.
Sexual Health News Headlines – Yahoo! News